Stay updated with breaking news from Bracanalysis Cdx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Myriad Genetics' EndoPredict test accurately identified premenopausal women with ER+, HER2- breast cancer who could safely avoid adjuvant chemotherapy SALT LAKE CITY, Aug. 31, 2022 1 that shows the
SALT LAKE CITY, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today...
Collaboration brings MyChoice CDx Plus Testing to Hamburg, Germany and Dijon, FranceLatest expansions represent Myriad's commitment to growing international lab partner program SALT LAKE CITY, Aug.
Collaboration brings MyChoice CDx Plus Testing to Hamburg, Germany and Dijon, FranceLatest expansions represent Myriad’s commitment to growing...
19.07.2022 - SALT LAKE CITY, July 19, 2022 (GLOBE NEWSWIRE) - Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, will host an Investor Day on Aug. 11, 2022, providing a strategic business update and overview of the ...